May 6 |
AxoGen, Inc. (NASDAQ:AXGN) Q1 2024 Earnings Call Transcript
|
May 5 |
AxoGen, Inc. (AXGN) Q1 2024 Earnings Call Transcript
|
May 3 |
AxoGen First Quarter 2024 Earnings: Misses Expectations
|
May 3 |
Axogen Inc (AXGN) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amidst Challenges
|
May 2 |
AxoGen (AXGN) Reports Q1 Loss, Lags Revenue Estimates
|
May 2 |
AxoGen Non-GAAP EPS of -$0.06 beats by $0.01, revenue of $41.4M misses by $0.65M
|
May 2 |
Axogen, Inc Reports First Quarter 2024 Financial Results
|
May 1 |
AxoGen Q1 2024 Earnings Preview
|
May 1 |
AxoGen, Inc. (NASDAQ:AXGN) is largely controlled by institutional shareholders who own 58% of the company
|
Apr 29 |
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
|